Skip to content
Catalyst

magnesium(2+)Finding

Magnesium(2+) has no detected effect on pre-eclampsia incidence

no difference foundVery limited evidenceFinding

01 · The sentence it was drawn from

“In the analysis of all trials, oral magnesium supplementation compared to no magnesium was associated with no significant difference in perinatal mortality (stillbirth and neonatal death prior to discharge) (risk ratio (RR) 1.10; 95% confidence interval (CI) 0.72 to 1.67; five trials, 5903 infants), small-for-gestational age (RR 0.76; 95% CI 0.54 to 1.07; three trials, 1291 infants), or pre-eclampsia (RR 0.87; 95% CI 0.58 to 1.32; three trials, 1042 women).”
Quoted verbatim from Magnesium supplementation in pregnancy.
This finding among the 8 findings on its endpoint

magnesium(2+)

Pre-eclampsia incidence

no difference found

Effect as reported

0.87risk ratio

CI 0.58 to 1.32

Who
n = 1,042 · Pregnant women in three randomised and quasi-randomised trials of oral magnesium supplementation versus placebo or no treatment
Dose studied
oral magnesium supplement, pooled forms (oxide, citrate, gluconate, aspartate, stearate) and doses

Very limited evidencePMID 24696187 · 2014

02 · The study

Study
meta-analysis
Participants
1,042
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

The Cochrane database of systematic reviews

Magnesium supplementation in pregnancy.

2014PMID 24696187doi 10.1002/14651858.CD000937.pub2

What else it reported1 finding · 1 compound · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y3RB1BBPM443JRXP7SRSZE